PARALLEL ADVISORS, LLC – Krystal Biotech, Inc. Transaction History
PARALLEL ADVISORS, LLC portfolio value:
$1.48M
portfolio value
PARALLEL ADVISORS, LLC quarter portfolio value change:
+6.15%
quarter
Krystal Biotech, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Increase | +0.35% | 74 shares | 91K | $69.7 | 21.35K |
Q2 2022 | share | Decrease | -13.36% | -3.28K shares | -245K | $65.66 | 21.28K |
Q1 2022 | share | Decrease | -27.83% | -9.47K shares | -738K | $66.54 | 24.56K |
Q4 2021 | share | Increase | +524.06% | 28.58K shares | 2.09M | $70.5 | 34.03K |
Q3 2021 | share | 0.00% | 0 shares | -86K | $52.21 | 5.45K | |
Q2 2021 | share | 0.00% | 0 shares | -49K | $68 | 5.45K | |
Q1 2021 | share | 0.00% | 0 shares | 93K | $77.04 | 5.45K | |
Q4 2020 | share | 0.00% | 0 shares | 92K | $60 | 5.45K | |
Q3 2020 | share | 0.00% | 0 shares | 10K | $43.05 | 5.45K | |
Q2 2020 | share | Increase | 0.00% | 5.45K shares | 225K | $41.42 | 5.45K |